| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | BELLICUM PHARMACEUTICALS, INC | 1,078,459 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Ikarian Capital, LLC | BELLICUM PHARMACEUTICALS, INC | 448,101 | 4.6% | EDGAR |
| SC 13D/A | 2023-11-24 | BAKER BROS. ADVISORS LP | BELLICUM PHARMACEUTICALS, INC | 2,365,472 | 20.0% | EDGAR |
| SC 13D | 2023-05-05 | BAKER BROS. ADVISORS LP | BELLICUM PHARMACEUTICALS, INC | 2,197,919 | 20.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | BELLICUM PHARMACEUTICALS, INC | 955,995 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Ikarian Capital, LLC | BELLICUM PHARMACEUTICALS, INC | 448,101 | 5.2% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | BELLICUM PHARMACEUTICALS, INC | 181,843 | 2.1% | EDGAR |
| SC 13D | 2022-11-18 | BELLICUM PHARMACEUTICALS, INC | BELLICUM PHARMACEUTICALS, INC | 691,639 | 7.4% | EDGAR |
| SC 13G/A | 2022-02-15 | ARMISTICE CAPITAL, LLC | BELLICUM PHARMACEUTICALS, INC | 932,052 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Ikarian Capital, LLC | BELLICUM PHARMACEUTICALS, INC | 496,756 | 5.9% | EDGAR |
| SC 13G | 2022-02-09 | VANGUARD GROUP INC | BELLICUM PHARMACEUTICALS, INC | 430,078 | 5.1% | EDGAR |
| SC 13G/A | 2021-02-16 | Boxer Capital, LLC | BELLICUM PHARMACEUTICALS, INC | 265,743 | 5.0% | EDGAR |
| SC 13G | 2021-02-16 | ARMISTICE CAPITAL, LLC | BELLICUM PHARMACEUTICALS, INC | 440,744 | 8.0% | EDGAR |
| SC 13G/A | 2021-02-10 | RENAISSANCE TECHNOLOGIES LLC | BELLICUM PHARMACEUTICALS, INC | 26,631 | 0.5% | EDGAR |
| SC 13G | 2021-01-11 | Ikarian Capital, LLC | BELLICUM PHARMACEUTICALS, INC | 500,000 | 9.9% | EDGAR |
| SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | BELLICUM PHARMACEUTICALS, INC | 1,750,000 | 3.4% | EDGAR |
| SC 13G | 2020-02-12 | RENAISSANCE TECHNOLOGIES LLC | BELLICUM PHARMACEUTICALS, INC | 2,583,840 | 5.2% | EDGAR |
| SC 13D/A | 2020-01-24 | BAKER BROS. ADVISORS LP | BELLICUM PHARMACEUTICALS, INC | 2,491,244 | 5.0% | EDGAR |
| SC 13G/A | 2019-09-06 | JPMORGAN CHASE & CO | BELLICUM PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
| SC 13G | 2019-08-26 | ARMISTICE CAPITAL, LLC | BELLICUM PHARMACEUTICALS, INC | 3,232,419 | 6.5% | EDGAR |